Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis.

Authors	Chenyang Zhao, Zhao Cui, Yimiao Zhang, Fang Wang, Xin Wang, Xuyang Cheng, Liqiang Meng, Gang Liu, Minghui Zhao
Journal	Chinese medical journal (Chin Med J (Engl)) Vol. 135 Issue 7 Pg. 866-868 (04 05 2022) ISSN: 2542-5641 [Electronic] China
PMID	34935693 (Publication Type: Letter)
Chemical References	Steroids Cyclosporine Leflunomide
Topics	Adult Cyclosporine Glomerulosclerosis, Focal Segmental (drug therapy) Humans Leflunomide (therapeutic use) Nephrosis, Lipoid (drug therapy) Nephrotic Syndrome Steroids

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!